Cargando…
Prognostic role of CHA(2)DS(2)-VASc score for mortality risk assessment in non-advanced idiopathic pulmonary fibrosis: a preliminary observation
During the last decade, the CHA(2)DS(2)-VASc score has been used for stratifying the mortality risk in both atrial fibrillation (AF) and non-AF patients. However, no previous study considered this score as a prognostic indicator in non-AF patients with mild-to-moderate idiopathic pulmonary fibrosis...
Autores principales: | Sonaglioni, Andrea, Caminati, Antonella, Re, Margherita, Elia, Davide, Trevisan, Roberta, Granato, Alberto, Zompatori, Maurizio, Lombardo, Michele, Harari, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039767/ https://www.ncbi.nlm.nih.gov/pubmed/36966265 http://dx.doi.org/10.1007/s11739-023-03219-6 |
Ejemplares similares
-
Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021) -
Mortality prediction using a modified R(2)CHA(2)DS(2)-VASc score among hospitalized COVID-19 patients
por: Levy, David, et al.
Publicado: (2022) -
Prognostic value of radiological index and clinical data in patients with COVID-19 infection
por: Elia, Davide, et al.
Publicado: (2022) -
CHA(2)DS(2)-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation
por: Sonaglioni, Andrea, et al.
Publicado: (2022) -
CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)